Option chain shows key data for AREV Life Sciences Global's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for AREV Life Sciences Global.

AREV Life Sciences Global (OTC:AREVF) Stock, Option Chain

AREV Life Sciences Global Corp is a fully integrated, early stage life science discovery enterprise dedicated to delivering solutions to public healthcare metrics through innovations and successful collaborations in the life science industry. The Company's focuses on dedication to generate revenue by way of novel therapeutic approaches to human nutrition and malnutrition, pandemic diseases, and neglected chronic co-morbidities.

Penny Stocks

AREVF

CSE:AREV

SUSTAINN, AREV&#39;s Ready to Use Therapeutic Foods discussed in leading article in HealthHIV

AREV Adds Dr. Apte to the SAB

AREV Corporate Update

AREV LIFE SCIENCES GLOBAL by AREV LIFE SCIENCES GLOBAL CORP.

AREV Life Sciences Global Corp

Trading Ideas

INTZ

Intrusion Shares Halted On Circuit Breaker To The Downside, Stock Now Up 226.7%

Movers

PDYN

Palladyne AI Shares Resume

MYSZ

My Size Shares Halted On Circuit Breaker To The Downside, Stock Now Up 61.4%

<p>Deep-pocketed investors have adopted a bearish approach towards MicroStrategy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MSTR usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 30 extraordinary options activities for MicroStrategy. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 36% leaning bullish and 46% bearish. Among these notable options, 9 are puts, totaling $801,496, and 21 are calls, amounting to $1,223,484.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $0.5 to $700.0 for MicroStrategy during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for MicroStrategy's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across MicroStrategy's significant trades, within a strike price range of $0.5 to $700.0, over the past month.</p>
<h3>MicroStrategy Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735310750_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MSTR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/03/25</td>
<td>$37.9</td>
<td>$37.25</td>
<td>$37.9</td>
<td>$370.00</td>
<td>$379.0K</td>
<td>601</td>
<td align="right">101</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$95.8</td>
<td>$90.65</td>
<td>$92.97</td>
<td>$500.00</td>
<td>$213.8K</td>
<td>1.0K</td>
<td align="right">0</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$34.15</td>
<td>$33.2</td>
<td>$33.97</td>
<td>$410.00</td>
<td>$149.4K</td>
<td>873</td>
<td align="right">44</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$93.9</td>
<td>$92.55</td>
<td>$93.61</td>
<td>$300.00</td>
<td>$93.6K</td>
<td>876</td>
<td align="right">10</td>
</tr>
<tr>
<td>MSTR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/27/24</td>
<td>$15.0</td>
<td>$14.1</td>
<td>$15.0</td>
<td>$350.00</td>
<td>$87.0K</td>
<td>3.0K</td>
<td align="right">358</td>
</tr>
</tbody>
</table>
</p>
<h3>About MicroStrategy</h3>
<p>MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web; MicroStrategy Server, which provides analytical processing and job management. The company's reportable operating segment is engaged in the design, development, marketing, and sales of its software platform through licensing arrangements and cloud-based subscriptions and related services.</p>
<p>In light of the recent options history for MicroStrategy, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of MicroStrategy</h3>
<ul>
<li>Currently trading with a volume of 555,038, the MSTR's price is up by 0.04%, now at $341.2. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 39 days.</li>
</ul>
<h3>Expert Opinions on MicroStrategy</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $600.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Bernstein has revised its rating downward to Outperform, adjusting the price target to $600. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for MicroStrategy with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Options

Markets

MSTR

MicroStrategy Unusual Options Activity For December 27

<p>Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) revealed 8 unusual trades.</p>
<p>Delving into the details, we found 50% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $1,977,143, and 5 were calls, valued at $222,954.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $85.0 to $135.0 for Novo Nordisk over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Novo Nordisk's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Novo Nordisk's substantial trades, within a strike price spectrum from $85.0 to $135.0 over the preceding 30 days.</p>
<h3>Novo Nordisk 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735310745_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$47.95</td>
<td>$45.9</td>
<td>$47.0</td>
<td>$135.00</td>
<td>$1.8M</td>
<td>1</td>
<td align="right">400</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$22.35</td>
<td>$21.45</td>
<td>$21.85</td>
<td>$85.00</td>
<td>$80.8K</td>
<td>386</td>
<td align="right">37</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/10/25</td>
<td>$28.25</td>
<td>$26.65</td>
<td>$27.15</td>
<td>$115.00</td>
<td>$65.1K</td>
<td>0</td>
<td align="right">24</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$12.85</td>
<td>$12.1</td>
<td>$12.35</td>
<td>$110.00</td>
<td>$45.6K</td>
<td>642</td>
<td align="right">0</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$4.6</td>
<td>$4.5</td>
<td>$4.6</td>
<td>$85.00</td>
<td>$41.3K</td>
<td>1.4K</td>
<td align="right">107</td>
</tr>
</tbody>
</table>
</p>
<h3>About Novo Nordisk</h3>
<p>With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.</p>
<p>In light of the recent options history for Novo Nordisk, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Novo Nordisk's Current Market Status</h3>
<ul>
<li>Trading volume stands at 354,286, with NVO's price up by 0.03%, positioned at $87.68.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 40 days.</li>
</ul>
<h3>What Analysts Are Saying About Novo Nordisk</h3>
<p>1 market experts have recently issued ratings for this stock, with a consensus target price of $105.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Outperform rating on Novo Nordisk with a target price of $105. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Novo Nordisk options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Behind the Scenes of Novo Nordisk's Latest Options Trends

<p>Financial giants have made a conspicuous bearish move on D-Wave Quantum. Our analysis of options history for D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) revealed 9 unusual trades.</p>
<p>Delving into the details, we found 33% of traders were bullish, while 66% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $57,500, and 7 were calls, valued at $284,330.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $7.0 to $15.0 for D-Wave Quantum during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of D-Wave Quantum stands at 2141.5, with a total volume reaching 2,098.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in D-Wave Quantum, situated within the strike price corridor from $7.0 to $15.0, throughout the last 30 days.</p>
<h3>D-Wave Quantum Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735310740_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>QBTS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/03/25</td>
<td>$1.75</td>
<td>$1.7</td>
<td>$1.7</td>
<td>$9.50</td>
<td>$59.5K</td>
<td>575</td>
<td align="right">401</td>
</tr>
<tr>
<td>QBTS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.0</td>
<td>$1.1</td>
<td>$1.3</td>
<td>$13.00</td>
<td>$52.0K</td>
<td>666</td>
<td align="right">0</td>
</tr>
<tr>
<td>QBTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$2.95</td>
<td>$2.55</td>
<td>$2.55</td>
<td>$9.00</td>
<td>$51.0K</td>
<td>3.7K</td>
<td align="right">5</td>
</tr>
<tr>
<td>QBTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.05</td>
<td>$0.9</td>
<td>$1.05</td>
<td>$15.00</td>
<td>$36.7K</td>
<td>8.3K</td>
<td align="right">402</td>
</tr>
<tr>
<td>QBTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.05</td>
<td>$0.9</td>
<td>$0.9</td>
<td>$15.00</td>
<td>$31.5K</td>
<td>8.3K</td>
<td align="right">752</td>
</tr>
</tbody>
</table>
</p>
<h3>About D-Wave Quantum</h3>
<p>D-Wave Quantum Inc. is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. The Company's mission is to unlock the power of quantum computing today to benefit business and society. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the Company's LeapTM cloud service.</p>
<p>Following our analysis of the options activities associated with D-Wave Quantum, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of D-Wave Quantum</h3>
<ul>
<li>With a volume of 9,537,329, the price of QBTS is up 3.43% at $10.24. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 90 days.</li>
</ul>
<h3>What Analysts Are Saying About D-Wave Quantum</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $8.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Roth MKM has decided to maintain their Buy rating on D-Wave Quantum, which currently sits at a price target of $7.<br />
&#x2A; An analyst from Benchmark has decided to maintain their Buy rating on D-Wave Quantum, which currently sits at a price target of $8.<br />
&#x2A; An analyst from Craig-Hallum persists with their Buy rating on D-Wave Quantum, maintaining a target price of $9. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest D-Wave Quantum options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


QBTS

D-Wave Quantum's Options Frenzy: What You Need to Know

<p>Watsco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSO#NYSE">WSO</a>) has outperformed the market over the past 5 years by 8.71% on an annualized basis producing an average annual return of 21.88%. Currently, Watsco has a market capitalization of $19.14 billion. </p>
<p><strong>Buying $1000 In WSO:</strong> If an investor had bought $1000 of WSO stock 5 years ago, it would be worth <strong>$2,682.49</strong> today based on a price of $475.00 for WSO at the time of writing.</p>
<h3>Watsco's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735310708_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


News

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Intrusion Shares Resumed Trading

AMBO

Ambow Education Holding Shares Resumed Trade

My Size Shares Resume

WIMI

WiMi Hologram Cloud Option Alert: Feb 21 $3 Calls Sweep (11) Near The Ask: 1600 At $0.901 With Open Interest Of 629; Stock Reference Price $2.3799

My Size Shares Halted On Circuit Breaker To The Downside, Stock Now Up 85.1%

<p>BWS Financial  analyst Hamed Khorsand   maintains Seadrill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SDRL#NYSE">SDRL</a>) with a Buy and maintains $80 price target.</p>


Price Target

Analyst Ratings

SDRL

BWS Financial Maintains Buy on Seadrill, Maintains $80 Price Target

Ambow Education Holding Shares Halted On Circuit Breaker To The Upside, Stock Now Up 94.6%

<p><strong>Bitcoin&#8217;s </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) could be headed for <a href="https://www.benzinga.com/money/bitcoin-price-prediction">a potential downturn</a>, according to a technical analyst citing on-chain data and expert analysis.</p>
<p><strong>What Happened:</strong> In a post on <strong>X</strong> on Dec. 26, Ali Martinez highlighted predictions from renowned analysts about a possible correction to $60,000. Here are the key perspectives:</p>
<ul>
<li><strong>Tone Vays: </strong>The former Wall Street quant suggests Bitcoin trading below $95,000 raises the probability of a pullback to $73,000, calling it "very, very bad."</li>
<li><strong>Peter Brandt: </strong>The veteran trader sees a breakdown of Bitcoin&#8217;s "broadening triangle" pattern, potentially leading to a retracement toward $70,000.</li>
</ul>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">Likewise, <a href="https://twitter.com/PeterLBrandt?ref_src=twsrc%5Etfw">@PeterLBrandt</a> said that <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> could be about to break down of a &quot;broadening triangle,&quot; which projects a retracement toward the $70,000 zone. <a href="https://t.co/QAVqL4AbpT">https://t.co/QAVqL4AbpT</a></p>
<p>&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1872271692917268925?ref_src=twsrc%5Etfw">December 26, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<ul>
<li><strong>Fundstrat&#8217;s Mark Newton: </strong>While Fundstrat expects Bitcoin to hit $250,000 by 2025, Newton predicts a downswing to $60,000 in the short term.</li>
<li><strong>Benjamin Cowen: </strong>The industry expert suggests Bitcoin's trajectory might mirror that of the Invesco QQQ Trust. If so, a flash crash to $60,000 could align with significant macro events, such as the inauguration of president-elect <strong>Donald Trump</strong>.</li>
</ul>
<p>Martinez also draws attention to critical on-chain data supporting the bearish outlook: a price correction to $70,000 seems plausible as Bitcoin trades below $93,806, with little support until $70,085.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42698826/bitcoin-options-worth-over-14-billion-expired-today-one-of-the-biggest-events-in-history-heres-what-crypto-investors-should-expect">Bitcoin Options Worth Over $14 Billion Expired Today, One Of The Biggest Events In History: Here&#8217;s What Crypto Investors Should Expect</a></strong></p>
<p><strong>Statistics: </strong>Over the past week, 33,000 BTC ($3.23 billion) has been transferred to exchanges, often a precursor to selling pressure.</p>
<p>Traders are realizing significant profits, with $7.17 billion taken off the table on Dec. 23. long positions on Binance having decreased sharply, from 66.73% to 53.60%.</p>
<p>Moreover, Bitcoin recently dipped below a critical support zone at $97,300. </p>
<p>Martinez argues that for the bearish scenario to be invalidated, Bitcoin must reclaim this level and maintain a daily close above $100,000. </p>
<p>A sustained recovery could then target $168,500.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42699697/bitcoin-ethereum-etfs-break-4-day-outflow-streak-net-592-inflows-on-thursday">Bitcoin, Ethereum ETFs Break 4-Day Outflow Streak, Net $592 Inflows On Thursday</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin Could Slide To $60,000, Technical Analyst Warns

VXRT

Vaxart Entered Into Modification Increasing Project Funding To $460.7M, With Trial Allotment Rising By $37.7M To $134.2M For Clinical Site Readiness And mRNA Comparator Distribution

<p>Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) has outperformed the market over the past 10 years by 10.73% on an annualized basis producing an average annual return of 22.07%. Currently, Apollo Global Management has a market capitalization of $98.65 billion. </p>
<p><strong>Buying $1000 In APO:</strong> If an investor had bought $1000 of APO stock 10 years ago, it would be worth <strong>$7,345.31</strong> today based on a price of $174.35 for APO at the time of writing.</p>
<h3>Apollo Global Management's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1735309809_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$1000 Invested In Apollo Global Management 10 Years Ago Would Be Worth This Much Today

Legal

NTRB

Nutriband Extends Chinese Patent To Macao Titled "Abuse and Misuse Deterrent Transdermal Systems"

<ul>
<li>TSLA</li>
<li>KULR</li>
<li>LUNR</li>
<li>NVDA</li>
<li>QS</li>
<li>RGTI</li>
<li>RKLB</li>
<li>AAPL</li>
<li>AMD</li>
<li>ACHR</li>
</ul>
<p>Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a></p>
<p>&nbsp;</p>


AAPL

ACHR

KULR

LUNR

NVDA

RGTI

RKLB

TSLA

Top 10 Trending Stocks On WallStreetBets As Of December 27, 2024 (Via Swaggy Stocks)

<p>Following considerable financial support <a href="https://www.benzinga.com/24/12/42382407/ripple-ceo-brad-garlinhouse-admits-204m-crypto-super-political-action-committee-wouldnt-exist-if-gary-gensler-hadnt-been-the-sec-chair">during the 2024 election</a>, the digital asset industry is positioning itself for a significant transformation in how it is regulated.</p>
<p><strong>What Happened: </strong>After years of dealing with unclear federal policies, and some hostile action by regulators, a change could be on the horizon under a new presidential administration, <a href="https://thehill.com/business/5054066-crypto-industry-2024-election-legislation/">according</a> to The Hill.</p>
<p>President-elect <strong>Donald Trump</strong>, who had earlier criticized digital currencies, shifted his stance during his campaign, to become the first presidential candidate to <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/38952866/trump-accepts-cryptocurrency-donations-in-bitcoin-ethereum-shiba-inu-dogecoin-and-more-say">receive donations in digital assets</a>.</p>
<p>This shift, coupled with bipartisan support within Congress, creates an opening for the passage of important legislation impacting the cryptocurrency sector.</p>
<p>According to <strong>Kristin Smith</strong>, head of the Blockchain Association, the combination of a <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41654131/pro-crypto-congress-in-2025-experts-see-stablecoins-as-key-area-for-advancement">crypto-friendly Congress</a> and president makes it possible to finally get supportive regulatory policy implemented, including measures about stablecoins and market structures.</p>
<p>Smith also stressed the need for unity within the industry, in order to properly articulate its needs to Washington D.C.</p>
<p>The <a href="https://www.benzinga.com/markets/cryptocurrency/24/05/39004550/exclusive-all-you-need-to-know-about-the-fit21-crypto-bill">FIT21 Act</a> is a key piece of legislation, intended to clarify the respective roles of the SEC and CFTC, to create needed regulatory boundaries.</p>
<p>The legislation was successful in the House last year, but failed in the Senate, therefore the crypto sector will aim to have it reintroduced. </p>
<p>Rep. <strong>French Hill</strong> (R-AR), incoming Chair of the House Financial Services Committee, has listed this type of regulatory policy as one of his top priorities.</p>
<p>The SEC&#8217;s approach under Gary Gensler, was perceived by many in the industry as being overly harsh, and focused on enforcement actions, rather than clear guidance.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42699697/bitcoin-ethereum-etfs-break-4-day-outflow-streak-net-592-inflows-on-thursday">Bitcoin, Ethereum ETFs Break 4-Day Outflow Streak, Net $592 Inflows On Thursday</a></strong></p>
<p><strong>Why It Matters: </strong>The new Trump administration is expected to be more accommodating.</p>
<p>Former SEC Commissioner <strong>Paul Atkins</strong>, known for his <a href="https://www.benzinga.com/24/12/42300549/paul-atkins-reportedly-tapped-for-sec-chair-under-trump-administration">support of crypto</a>, has already been nominated to replace Gensler.</p>
<p>Trump&#8217;s announcement of a new &#8220;<a href="https://www.benzinga.com/24/12/42356067/venture-capitalist-david-sacks-appointed-as-white-house-ai-crypto-czar-by-trump">crypto council</a>&#8221; led by <strong>David Sacks</strong> is another indication of a more friendly administration toward crypto.</p>
<p>The future leadership of the CFTC remains in question, but with a number of well regarded crypto advocates being mentioned as candidates.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42690488/are-donald-trumps-ambitious-bitcoin-goals-feasible">Are Donald Trump&#8217;s Ambitious Bitcoin Goals Feasible?</a></strong></li>
</ul>
<p><em>Image: Flickr</em></p>


Crypto Industry Anticipates Policy Overhaul Under Trump Administration

AREV Life Sciences Global

Comments

AREV Life Sciences Global

AREV Life Sciences Global (AREVF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga